Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Postoperative Stage II/III Colon Cancer
Interventions
DRUG

ART-123 (3-day ART)

ART-123 380 U/kg infusion once daily on days 1-3 in each cycle

DRUG

ART-123 (1-day ART)

ART-123 380 U/kg infusion once on day 1 and placebo infusion once daily on days 2-3 in each cycle

DRUG

Placebo

Placebo infusion once daily on days 1-3 in each cycle

Trial Locations (2)

Unknown

Kobe

Nerima City

All Listed Sponsors
lead

Asahi Kasei Pharma Corporation

INDUSTRY

NCT02792842 - Exploratory Study of ART-123 for the Prevention of Cancer Treatment Related Symptoms in Patients With Postoperative Stage II / III Colon Cancer | Biotech Hunter | Biotech Hunter